StockData
Supernus, Inc. logo

Supernus, Inc. (INDV) stock

INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$35.37+0.12 (+0.34%)

Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –

Supernus ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Supernus's ebitda for the twelve months ending Sep 30, 2026 was $565.00M, up 135.4% year over year. For fiscal 2025 it was $272.00M, up 403.7% from the year before. The highest annual figure on record is $272.00M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$272.00M+403.7%
FY2024Dec 31, 2024$54.00M–
FY2023Dec 31, 2023-$137.00M–
FY2022Dec 31, 2022-$61.00M-126.8%
FY2021Dec 31, 2021$228.00M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$181.00M+293.5%
Q2 FY2026Jun 30, 2026$162.00M+118.9%
Q1 FY2026Mar 31, 2026$139.00M+101.4%
Q4 FY2025Dec 31, 2025$83.00M+62.7%
Q3 FY2025Sep 30, 2025$46.00M+17.9%
Q2 FY2025Jun 30, 2025$74.00M–
Q1 FY2025Mar 31, 2025$69.00M-13.7%
Q4 FY2024Dec 31, 2024$51.00M–
Q3 FY2024Sep 30, 2024$39.00M–
Q2 FY2024Jun 30, 2024-$116.00M–
Q1 FY2024Mar 31, 2024$80.00M–

More Supernus figures

See a number that looks wrong?